346 related articles for article (PubMed ID: 16818943)
1. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
Kashihara K; Ohno M; Kawada S; Okumura Y
J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943
[TBL] [Abstract][Full Text] [Related]
2. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
[TBL] [Abstract][Full Text] [Related]
3. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H
Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
7. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
8. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of MIBG myocardial scintigraphy in Parkinson disease].
Orimo S
Brain Nerve; 2012 Apr; 64(4):403-12. PubMed ID: 22481513
[TBL] [Abstract][Full Text] [Related]
10. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
[TBL] [Abstract][Full Text] [Related]
11. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
12. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
Rascol O; Schelosky L
Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
[TBL] [Abstract][Full Text] [Related]
13. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
[TBL] [Abstract][Full Text] [Related]
14. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
Raffel DM; Koeppe RA; Little R; Wang CN; Liu S; Junck L; Heumann M; Gilman S
J Nucl Med; 2006 Nov; 47(11):1769-77. PubMed ID: 17079809
[TBL] [Abstract][Full Text] [Related]
15. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
[TBL] [Abstract][Full Text] [Related]
16. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
17. (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
Kim JS; Park HE; Oh YS; Song IU; Yang DW; Park JW; Lee KS
J Neurol Sci; 2015 Oct; 357(1-2):173-7. PubMed ID: 26208800
[TBL] [Abstract][Full Text] [Related]
18. Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies.
Kobayashi S; Tateno M; Morii H; Utsumi K; Saito T
Psychiatry Res; 2009 Oct; 174(1):76-80. PubMed ID: 19766460
[TBL] [Abstract][Full Text] [Related]
19. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
Yoshita M; Taki J; Yokoyama K; Noguchi-Shinohara M; Matsumoto Y; Nakajima K; Yamada M
Neurology; 2006 Jun; 66(12):1850-4. PubMed ID: 16801649
[TBL] [Abstract][Full Text] [Related]
20. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
Yoshita M; Taki J; Yamada M
J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
